Etienne Nzabarushimana, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heavy Ions | 2 | 2015 | 11 | 0.600 |
Why?
|
| Databases, Nucleic Acid | 1 | 2017 | 204 | 0.540 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 786 | 0.490 |
Why?
|
| Clostridium Infections | 1 | 2022 | 557 | 0.480 |
Why?
|
| Iron | 2 | 2015 | 1786 | 0.320 |
Why?
|
| Lung | 3 | 2016 | 9994 | 0.270 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2016 | 88 | 0.240 |
Why?
|
| Epigenesis, Genetic | 3 | 2016 | 3758 | 0.240 |
Why?
|
| Software | 1 | 2017 | 4419 | 0.220 |
Why?
|
| DNA Methylation | 4 | 2016 | 4373 | 0.190 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 551 | 0.160 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2016 | 330 | 0.140 |
Why?
|
| Radiation, Ionizing | 1 | 2016 | 251 | 0.130 |
Why?
|
| Linear Energy Transfer | 1 | 2015 | 152 | 0.120 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 881 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 783 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2015 | 371 | 0.110 |
Why?
|
| Space Flight | 1 | 2014 | 214 | 0.090 |
Why?
|
| Protons | 1 | 2015 | 1114 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2014 | 506 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 547 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 22023 | 0.090 |
Why?
|
| Lung Injury | 1 | 2014 | 424 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 1764 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3616 | 0.060 |
Why?
|
| Particulate Matter | 1 | 2015 | 2559 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7408 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4393 | 0.050 |
Why?
|
| Mice | 4 | 2016 | 81208 | 0.050 |
Why?
|
| Macrophages | 1 | 2015 | 5745 | 0.040 |
Why?
|
| Animals | 5 | 2016 | 167963 | 0.040 |
Why?
|
| Algorithms | 1 | 2017 | 13981 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 844 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 2015 | 67 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 65017 | 0.030 |
Why?
|
| Azacitidine | 1 | 2016 | 334 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 569 | 0.030 |
Why?
|
| Male | 5 | 2024 | 359744 | 0.030 |
Why?
|
| Humans | 5 | 2024 | 760621 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 756 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3361 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 7593 | 0.020 |
Why?
|
| Epigenomics | 1 | 2015 | 936 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13262 | 0.020 |
Why?
|
| Public Health | 1 | 2022 | 2653 | 0.020 |
Why?
|
| Time Factors | 2 | 2024 | 40165 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2442 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2583 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4713 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10827 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2016 | 2809 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8624 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41335 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72461 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 169152 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 220352 | 0.010 |
Why?
|
| Female | 1 | 2024 | 391270 | 0.000 |
Why?
|